Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
CALL
DXC Technology
DXC
$1.77B
| $932K | ﹤0.01% |
31,600
-12,800
| -29% | -$545K |
|
3677
PUT
Lear
LEA
$7.93B
| $931K | ﹤0.01% |
7,900
+5,200
| +193% | +$632K |
|
3678
Sunrun
RUN
$2.24B
| $931K | ﹤0.01% |
55,708
-17,777
| -24% | -$310K |
|
3679
Banco Santander Chile
BSAC
$16.8B
| $930K | ﹤0.01% |
+33,216
| New | +$959K |
|
3680
Commerce Bancshares
CBSH
$8.51B
| $930K | ﹤0.01% |
21,561
-5,060
| -19% | -$211K |
|
3681
iShares Russell 2000 Value ETF
IWN
$14.5B
| $930K | ﹤0.01% |
7,787
-952
| -11% | -$112K |
|
|
PS
3682
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $928K | ﹤0.01% |
55,250
-616,645
| -92% | -$13.3M |
|
3683
Central Pacific Financial
CPF
$1.01B
| $923K | ﹤0.01% |
32,456
+58
| +0.2% | +$1.67K |
|
3684
Verra Mobility
VRRM
$778M
| $922K | ﹤0.01% |
64,288
-58,476
| -48% | -$814K |
|
|
USCR
3685
DELISTED
U S Concrete, Inc.
USCR
| $921K | ﹤0.01% |
16,634
-4,682
| -22% | -$219K |
|
3686
Levi Strauss
LEVI
$9.35B
| $919K | ﹤0.01% |
48,235
+28,366
| +143% | +$526K |
|
|
AVNS
3687
DELISTED
Avanos Medical
AVNS
| $918K | ﹤0.01% |
24,495
-13,042
| -35% | -$498K |
|
|
VISN
3688
Vistance Networks Inc
VISN
$2.28B
| $918K | ﹤0.01% |
78,040
-127,655
| -62% | -$1.64M |
|
3689
CALL
ManpowerGroup
MAN
$2.57B
| $918K | ﹤0.01% |
10,900
+1,100
| +11% | +$95.9K |
|
|
TVTY
3690
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $915K | ﹤0.01% |
55,097
-53,416
| -49% | -$924K |
|
|
SPR
3691
PUT
DELISTED
Spirit AeroSystems
SPR
| $913K | ﹤0.01% |
11,100
-3,400
| -23% | -$266K |
|
|
HA
3692
CALL
DELISTED
Hawaiian Holdings, Inc.
HA
| $911K | ﹤0.01% |
34,700
+18,800
| +118% | +$494K |
|
3693
CALL
Ball Corp
BALL
$16.7B
| $910K | ﹤0.01% |
12,500
+3,100
| +33% | +$231K |
|
3694
TG Therapeutics
TGTX
$7.59B
| $910K | ﹤0.01% |
162,212
+96,449
| +147% | +$672K |
|
3695
CALL
Zoetis
ZTS
$32.4B
| $910K | ﹤0.01% |
7,300
-33,200
| -82% | -$4.01M |
|
3696
Griffon
GFF
$4.88B
| $908K | ﹤0.01% |
43,310
-9,783
| -18% | -$175K |
|
3697
World Acceptance Corp
WRLD
$886M
| $908K | ﹤0.01% |
7,131
-936
| -12% | -$132K |
|
3698
CALL
SL Green Realty
SLG
$3.86B
| $907K | ﹤0.01% |
+11,466
| New | +$892K |
|
3699
TTEC Holdings
TTEC
$127M
| $907K | ﹤0.01% |
18,939
+2,839
| +18% | +$133K |
|
|
ESPR
3700
DELISTED
Esperion Therapeutics
ESPR
| $903K | ﹤0.01% |
24,607
-7,495
| -23% | -$297K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.